These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9598746)

  • 1. Xanthomonas maltophilia: an emerging pathogen in patients with HIV disease.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Int J STD AIDS; 1998 Apr; 9(4):201-7. PubMed ID: 9598746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
    Calza L; Manfredi R; Chiodo F
    Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV disease and bacterial superinfections due to Xanthomonas spp.: a frequent association.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Infez Med; 1999; 7(1):43-48. PubMed ID: 12728205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
    Garazi M; Singer C; Tai J; Ginocchio CC
    J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.
    Friedman ND; Korman TM; Fairley CK; Franklin JC; Spelman DW
    J Infect; 2002 Jul; 45(1):47-53. PubMed ID: 12217732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Eur J Epidemiol; 2000 Feb; 16(2):111-8. PubMed ID: 10845259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients.
    Victor MA; Arpi M; Bruun B; Jønsson V; Hansen MM
    Scand J Infect Dis; 1994; 26(2):163-70. PubMed ID: 8036472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging gram-negative pathogens in the immunocompromised host: Agrobacterium radiobacter septicemia during HIV disease.
    Manfredi R; Nanetti A; Ferri M; Mastroianni A; Coronado OV; Chiodo F
    New Microbiol; 1999 Oct; 22(4):375-82. PubMed ID: 10555210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmonella and shigella bacteraemia in Zimbabwe.
    Pithie AD; Malin AS; Robertson VJ
    Cent Afr J Med; 1993 Jun; 39(6):110-2. PubMed ID: 8131197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients.
    Cairo J; Hachem R; Rangaraj G; Granwehr B; Raad I
    Clin Microbiol Infect; 2011 Nov; 17(11):1711-6. PubMed ID: 21595787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of clinical characteristics and drug sensitivity tests of lower respiratory tract infection by Xanthomonas maltophilia].
    Liu Z; Zhao Z; Xiong J
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):211-3. PubMed ID: 11775914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nosocomial Stenotrophomonas maltophilia infections in a university hospital].
    Caylan R; Yilmaz G; Sucu N; Bayraktar O; Aydin K; Kaklikkaya N; Aydin F; Köksal I
    Mikrobiyol Bul; 2005 Jan; 39(1):25-33. PubMed ID: 15900834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease.
    Manfredi R; Nanetti A; Ferri M; Mastroianni A; Coronado OV; Chiodo F
    J Infect; 1999 Sep; 39(2):146-52. PubMed ID: 10609533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated.
    Vartivarian SE; Papadakis KA; Anaissie EJ
    Arch Intern Med; 1996 Feb; 156(4):433-5. PubMed ID: 8607729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Streptococcus pneumoniae bacteremia and HIV infection. Retrospective study of 41 episodes in 30 patients].
    Torri O; Mariel C; Veyssier P; Cevallos R; Bouchaud O; Carbon C; Jarousse B; Masson H; Patey O; Fantin B
    Presse Med; 1994 Jun; 23(21):972-5. PubMed ID: 7937643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients.
    Lai CH; Wong WW; Chin C; Huang CK; Lin HH; Chen WF; Yu KW; Liu CY
    Clin Microbiol Infect; 2006 Oct; 12(10):986-91. PubMed ID: 16961635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.
    Metan G; Hayran M; Hascelik G; Uzun O
    Scand J Infect Dis; 2006; 38(6-7):527-31. PubMed ID: 16798705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.